Skip to main navigation Skip to search Skip to main content

U.S. Clinical Trial: Fox Chase Cancer Center Listed a New Clinical Trial to Study Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

Press/Media

PeriodJan 24 2024

Media coverage

1

Media coverage

  • TitleU.S. Clinical Trial: Fox Chase Cancer Center Listed a New Clinical Trial to Study Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date01/24/24
    PersonsPeter Abdelmessieh